Stay updated on Subcutaneous Atezolizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.

Latest updates to the Subcutaneous Atezolizumab in NSCLC Clinical Trial page
- Check5 days agoChange DetectedThe page’s revision label changed from v3.5.2 to v3.5.3 in the footer, signaling a new release of the page’s record history. This is a minor update to the page’s versioning and does not alter the study details presented.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe history now shows a new revision entry (v3.5.2) and the previous revision (v3.5.0) has been removed from the version history.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check48 days agoChange DetectedA new revision entry v3.5.0 was added to the Record History and the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check56 days agoChange DetectedThe study record history now includes a new revision v3.4.3 and removes revision v3.4.2.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision: v3.4.2 was added to the history. The government funding notice banner previously shown on the page was removed.SummaryDifference0.8%

- Check91 days agoChange DetectedA new government funding notice was added and the recruitment status was updated to Active, not recruiting (revision v3.4.1, 2026-01-29). Earlier statuses such as insufficient accrual and Terminated were removed (revision v3.4.0, 2025-08-06).SummaryDifference2%

Stay in the know with updates to Subcutaneous Atezolizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Atezolizumab in NSCLC Clinical Trial page.